Clinical Trial

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.

Study acronym: PATH
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
We seek to characterise the burden and outcomes of and understand the current experience of people who inject drugs admitted to hospital with invasive injecting-related infections, in order to implement and evaluate strategies to improve completion of therapy and reduce patient-directed discharges, with ultimate benefit to the patient and health service.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-14.
Trial Details
NCT Number NCT06220370
Lead Sponsor Kirby Institute
Conditions Invasive Fungal Infections, Invasive Bacterial Infection, Injection Site Infection, Infection, Bacterial, Infection, Fungal, Infection, Soft Tissue
Enrollment 300 participants
Start Date 2024-03-01
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-02-20